Literature DB >> 26727422

A dysbiotic subpopulation of alcohol-dependent subjects.

Philippe de Timary1, Sophie Leclercq1,2, Peter Stärkel3, Nathalie Delzenne4.   

Abstract

The vast majority of studies that assessed the importance of biological factors for the development of psychiatric disorders focused on processes occurring at the brain level. Alcohol-dependence is a very frequent psychiatric disorder where psycho-pharmacological interventions are only of moderate efficacy. Our laboratory has recently described that a subpopulation of alcohol-dependent subjects, that accounted for approximately 40% of individuals tested, presented with an increased intestinal permeability, with a dysbiosis, with alterations in the metabolomic content of faeces--that could play a role in the increased permeability--and finally with a more severe profile of alcohol-dependence than the other non-dysbiotic subpopulation. In this addendum, we discuss the implications of our observations for the pathophysiology of alcohol dependence where we try to discriminate which addiction dimensions are likely related to the gut microbiota alterations and whether these alterations are the cause or the consequence of drinking habits.

Entities:  

Keywords:  alcohol dependence; alcohol use disorders; behavior; depression; gut microbiota; gut permeability; gut-brain axis; leaky gut; negative reinforcement

Mesh:

Year:  2015        PMID: 26727422      PMCID: PMC4826101          DOI: 10.1080/19490976.2015.1107696

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  41 in total

Review 1.  Drug addiction: the neurobiology of behaviour gone awry.

Authors:  Nora D Volkow; Ting-Kai Li
Journal:  Nat Rev Neurosci       Date:  2004-12       Impact factor: 34.870

2.  Addiction is a brain disease, and it matters.

Authors:  A I Leshner
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

Review 3.  Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression.

Authors:  Ruth Ann Luna; Jane A Foster
Journal:  Curr Opin Biotechnol       Date:  2014-11-21       Impact factor: 9.740

Review 4.  The gut microbiome and diet in psychiatry: focus on depression.

Authors:  Sarah Dash; Gerard Clarke; Michael Berk; Felice N Jacka
Journal:  Curr Opin Psychiatry       Date:  2015-01       Impact factor: 4.741

5.  Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

Authors:  H R Kranzler; J Van Kirk
Journal:  Alcohol Clin Exp Res       Date:  2001-09       Impact factor: 3.455

Review 6.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

7.  Naltrexone in the treatment of alcohol dependence.

Authors:  J R Volpicelli; A I Alterman; M Hayashida; C P O'Brien
Journal:  Arch Gen Psychiatry       Date:  1992-11

8.  Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.

Authors:  F M Paille; J D Guelfi; A C Perkins; R J Royer; L Steru; P Parot
Journal:  Alcohol Alcohol       Date:  1995-03       Impact factor: 2.826

9.  Naltrexone and coping skills therapy for alcohol dependence. A controlled study.

Authors:  S S O'Malley; A J Jaffe; G Chang; R S Schottenfeld; R E Meyer; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-11

10.  Predisposition to petty criminality in Swedish adoptees. II. Cross-fostering analysis of gene-environment interaction.

Authors:  C R Cloninger; S Sigvardsson; M Bohman; A L von Knorring
Journal:  Arch Gen Psychiatry       Date:  1982-11
View more
  12 in total

Review 1.  Gut microbiome and liver disease.

Authors:  Naga S Betrapally; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

Review 2.  Is adolescence the missing developmental link in Microbiome-Gut-Brain axis communication?

Authors:  Jessica Flannery; Bridget Callaghan; Thomas Sharpton; Philip Fisher; Jennifer Pfeifer
Journal:  Dev Psychobiol       Date:  2019-01-28       Impact factor: 3.038

Review 3.  A potential role for the gut microbiome in substance use disorders.

Authors:  Katherine R Meckel; Drew D Kiraly
Journal:  Psychopharmacology (Berl)       Date:  2019-04-14       Impact factor: 4.530

Review 4.  Do your gut microbes affect your brain dopamine?

Authors:  Camila González-Arancibia; Jocelyn Urrutia-Piñones; Javiera Illanes-González; Jonathan Martinez-Pinto; Ramón Sotomayor-Zárate; Marcela Julio-Pieper; Javier A Bravo
Journal:  Psychopharmacology (Berl)       Date:  2019-05-17       Impact factor: 4.530

Review 5.  The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: A 'Ménage à Trois'?

Authors:  Jamie E Temko; Sofia Bouhlal; Mehdi Farokhnia; Mary R Lee; John F Cryan; Lorenzo Leggio
Journal:  Alcohol Alcohol       Date:  2017-07-01       Impact factor: 2.826

Review 6.  Similarities in alcohol and opioid withdrawal syndromes suggest common negative reinforcement mechanisms involving the interoceptive antireward pathway.

Authors:  Sean J O'Sullivan; James S Schwaber
Journal:  Neurosci Biobehav Rev       Date:  2021-02-26       Impact factor: 9.052

Review 7.  Considering the Microbiome in Stress-Related and Neurodevelopmental Trajectories to Schizophrenia.

Authors:  Kevin W Hoffman; Jakleen J Lee; Cheryl M Corcoran; David Kimhy; Thorsten M Kranz; Dolores Malaspina
Journal:  Front Psychiatry       Date:  2020-07-03       Impact factor: 4.157

Review 8.  Psychotropics and the Microbiome: a Chamber of Secrets….

Authors:  Sofia Cussotto; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2019-02-26       Impact factor: 4.530

Review 9.  Organ-organ communication: The liver's perspective.

Authors:  Fei Wang; Kwok-Fai So; Jia Xiao; Hua Wang
Journal:  Theranostics       Date:  2021-01-16       Impact factor: 11.556

Review 10.  The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome.

Authors:  Stephen Malnick; Yaakov Maor
Journal:  Visc Med       Date:  2020-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.